Shanghai Xuerong Biotechnology Co., Ltd. (SHE:300511)
China flag China · Delayed Price · Currency is CNY
4.150
0.00 (0.00%)
At close: Oct 28, 2026

SHE:300511 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
128.39161.45167.95252.67363.82340.77
Short-Term Investments
---0.06--
Trading Asset Securities
----270-
Cash & Short-Term Investments
128.39161.45167.95252.72633.82340.77
Cash Growth
22.31%-3.87%-33.54%-60.13%86.00%-55.16%
Accounts Receivable
44.1243.7731.3933.4829.0228.86
Other Receivables
6.28.65.556.2850.1318.89
Receivables
50.3252.3736.9539.7679.1547.74
Inventory
379.56371.68325.34442.86443.28384.08
Prepaid Expenses
-3.982.95.743.972.11
Other Current Assets
29.3916.5613.1725.5132.34100.24
Total Current Assets
587.66606.04546.31766.61,193874.94
Property, Plant & Equipment
2,5642,6642,9653,4602,5792,945
Long-Term Investments
9.4812.0515.616.2421.4632.61
Other Intangible Assets
290.57299.43299.63306.9221.72328.38
Long-Term Deferred Tax Assets
-----12.83
Long-Term Deferred Charges
10.426.147.9121.8126.4847.77
Other Long-Term Assets
34.5614.0919.8730.6830.8295.96
Total Assets
3,4963,6013,8554,6024,0724,337

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
315.02320.95298.35318.15215.87214.13
Accrued Expenses
55.1660.5278.0766.9261.8455.59
Short-Term Debt
910.74926.15985.851,036575.76777.49
Current Portion of Long-Term Debt
86.1114.07146.19168.69170.4248.23
Current Portion of Leases
-1.151.054.011.131.07
Current Income Taxes Payable
6.340---0.01
Current Unearned Revenue
8.56.4720.627.1616.2314.15
Other Current Liabilities
271.48327.48418.11512.47256.29295.98
Total Current Liabilities
1,6531,7571,9482,1131,2981,607
Long-Term Debt
211.61219.98960.21948.27973.69954.69
Long-Term Leases
16.1228.9554.2924.4123.4523.45
Long-Term Unearned Revenue
52.1257.1960.5651.1243.8949.68
Other Long-Term Liabilities
8724.967.9433.08107.6451.12
Total Liabilities
2,0202,0883,0313,1702,4462,686

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
640.85640.85498.82498.78503.04441.92
Additional Paid-In Capital
1,3281,314741.98741.82753.99471.77
Retained Earnings
-385.58-338.18-367.98249.09437.16724.38
Treasury Stock
-----16.43-34.7
Comprehensive Income & Other
-7.34-4.765.8164.8365.5165.98
Total Common Equity
1,5761,612938.631,5551,7431,669
Minority Interest
-99.77-98.53-115.31-122.15-117.43-17.5
Shareholders' Equity
1,4761,513823.321,4321,6261,652
Total Liabilities & Equity
3,4963,6013,8554,6024,0724,337

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
1,2251,2902,1482,1811,7442,005
Net Cash (Debt)
-1,096-1,129-1,980-1,928-1,111-1,664
Net Cash Growth
------
Net Cash Per Share
-1.62-1.89-3.98-3.90-2.28-3.85
Filing Date Shares Outstanding
840.78640.85498.82498.78503.04507.6
Total Common Shares Outstanding
840.78640.85498.82498.78503.04441.92
Working Capital
-1,066-1,151-1,402-1,346-104.97-731.7
Book Value Per Share
1.872.521.883.123.473.78
Tangible Book Value
1,2851,313638.991,2481,5221,341
Tangible Book Value Per Share
1.532.051.282.503.023.03
Buildings
-2,3262,3162,2831,9291,922
Machinery
-2,5892,6872,5982,1872,209
Construction In Progress
-20.2853.49360.3168.28151.74